Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1979 Mar 31;1(6167):848–850. doi: 10.1136/bmj.1.6167.848

Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in life-threatening asthma.

P Bloomfield, J Carmichael, G R Petrie, N P Jewell, G K Crompton
PMCID: PMC1598545  PMID: 373852

Abstract

A double-blind crossover trial was carried out during 22 episodes of life-threatening asthma in 19 patients to compare salbutamol given as a 500 microgram intravenous injection and as a 0 . 5% solution administered by intermittent positive-pressure breathing (IPPB) for three minutes. Relief of pulsus paradoxus was significantly better after IPPB than the intravenous treatment. Both treatments significantly improved the peak expiratory flow rate. Salbutamol given intravenously produced a mean increase in heart rate of over 20 beats/min five minutes after treatment compared with the relief of tachycardia that occurred after administration by IPPB. Four patients had noticeable cardiovascular side effects after salbutamol given intravenously, but no such effects were noticed after administration by IPPB. Two patients withdrawn shortly after entry into the trial because of a worsening clinical condition had received intravenous salbutamol. It is concluded that salbutamol given by IPPB is better than that given by slow intravenous injection in severe acute asthma.

Full text

PDF
849

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crompton G. K. Special problems of clinical trials in status asthmaticus [proceedings]. Br J Dis Chest. 1977 Oct;71(4):242–244. [PubMed] [Google Scholar]
  2. Fitchett D. H., McNicol M. W., Riordan J. F. Intravenous salbutamol in management of status asthmaticus. Br Med J. 1975 Jan 11;1(5949):53–55. doi: 10.1136/bmj.1.5949.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hetzel M. R., Clark T. J. Comparison of intravenous and aerosol salbutamol. Br Med J. 1976 Oct 16;2(6041):919–919. doi: 10.1136/bmj.2.6041.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lawford P., Jones B. J., Milledge J. S. Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma. Br Med J. 1978 Jan 14;1(6105):84–84. doi: 10.1136/bmj.1.6105.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Williams S. J., Parrish R. W., Seaton A. Comparison of intravenous aminophylline and salbutamol in severe asthma. Br Med J. 1975 Dec 20;4(5998):685–685. doi: 10.1136/bmj.4.5998.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Williams S., Seaton A. Intravenous or inhaled salbutamol in severe acute asthma? Thorax. 1977 Oct;32(5):555–558. doi: 10.1136/thx.32.5.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Woolcock A. J., Read J. Improvement in bronchial asthma not reflected in forced expiratory volume. Lancet. 1965 Dec 25;2(7426):1323–1325. doi: 10.1016/s0140-6736(65)92343-3. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES